King Charles III hospitalized for prostate surgery

Date:

King Charles III, 75, was hospitalized this Friday morning due to a “benign” enlarged prostate, Buckingham Palace announced. “The king was admitted to a London hospital this morning for scheduled treatment. Her Majesty would like to thank everyone who has sent her well wishes over the past week and is delighted to learn that her diagnosis is having a positive impact on public health awareness,” the palace said.

The royal family had, in a rare move, announced on January 17 that the king would soon have prostate surgery. “Like thousands of men each year, the king consulted for an enlarged prostate. What His Majesty is suffering from is benign and he will go to hospital next week for a corrective procedure,” the palace said in a brief statement, specifying that his public engagements would be postponed for a short period to allow him to to recover.

Kate still hospitalized

This is the first time since his accession to the throne on September 8, 2022 upon the death of his mother Queen Elizabeth II that the palace has publicly discussed the state of health of the sovereign. Prostate hypertrophy is a very common pathology in men of a certain age and which, if left untreated, can lead to a progressive deterioration in bladder function as well as urinary infections.

This article is originally published on .dna.fr

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Electric Scooter XElectric Scooter X

Popular

More like this
Related

Fighting fake news on agricultural Europe, CapCom 24-25 kicks off in Italy

Raising awareness among citizens, and not only farmers, about...

Socialists Against Von Der Leyen for New EU Commission: Our Support Is Not a Blank Check

European Socialists fear the composition of the next EU...

Northvolt to Suspend Part of Production. Staff Cuts Coming

The electric car market is not growing as expected,...

London-based Puraffinity raises €7.9m to remove PFAS from water; names Vincent Caillaud as new CEO

London-based Puraffinity, a startup developing technologies to remove perfluoroalkyl...